Expression of cholera toxin B–proinsulin fusion protein in lettuce and tobacco chloroplasts – oral administration protects against development of insulitis in non‐obese diabetic mice
Open Access
- 9 May 2007
- journal article
- Published by Wiley in Plant Biotechnology Journal
- Vol. 5 (4), 495-510
- https://doi.org/10.1111/j.1467-7652.2007.00259.x
Abstract
Lettuce and tobacco chloroplast transgenic lines expressing the cholera toxin B subunit–human proinsulin (CTB-Pins) fusion protein were generated. CTB-Pins accumulated up to ~16% of total soluble protein (TSP) in tobacco and up to ~2.5% of TSP in lettuce. Eight milligrams of powdered tobacco leaf material expressing CTB-Pins or, as negative controls, CTB–green fluorescent protein (CTB-GFP) or interferon–GFP (IFN-GFP), or untransformed leaf, were administered orally, each week for 7 weeks, to 5-week-old female non-obese diabetic (NOD) mice. The pancreas of CTB-Pins-treated mice showed decreased infiltration of cells characteristic of lymphocytes (insulitis); insulin-producing β-cells in the pancreatic islets of CTB-Pins-treated mice were significantly preserved, with lower blood or urine glucose levels, by contrast with the few β-cells remaining in the pancreatic islets of the negative controls. Increased expression of immunosuppressive cytokines, such as interleukin-4 and interleukin-10 (IL-4 and IL-10), was observed in the pancreas of CTB-Pins-treated NOD mice. Serum levels of immunoglobulin G1 (IgG1), but not IgG2a, were elevated in CTB-Pins-treated mice. Taken together, T-helper 2 (Th2) lymphocyte-mediated oral tolerance is a likely mechanism for the prevention of pancreatic insulitis and the preservation of insulin-producing β-cells. This is the first report of expression of a therapeutic protein in transgenic chloroplasts of an edible crop. Transplastomic lettuce plants expressing CTB-Pins grew normally and transgenes were maternally inherited in T1 progeny. This opens up the possibility for the low-cost production and delivery of human therapeutic proteins, and a strategy for the treatment of various other autoimmune diseases.Keywords
This publication has 63 references indexed in Scilit:
- Field production and functional evaluation of chloroplast‐derived interferon‐α2bPlant Biotechnology Journal, 2007
- Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasisPlant Biotechnology Journal, 2007
- Receptor‐mediated oral delivery of a bioencapsulated green fluorescent protein expressed in transgenic chloroplasts into the mouse circulatory systemThe FASEB Journal, 2006
- Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic SubjectsDiabetes Care, 2005
- The production of recombinant pharmaceutical proteins in plantsNature Reviews Genetics, 2003
- A chloroplast transgenic approach to hyper‐express and purify Human Serum Albumin, a protein highly susceptible to proteolytic degradationPlant Biotechnology Journal, 2003
- Molecular strategies for gene containment in transgenic cropsNature Biotechnology, 2002
- Expression of an Antimicrobial Peptide via the Chloroplast Genome to Control Phytopathogenic Bacteria and FungiPlant Physiology, 2001
- Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplastsJournal of Molecular Biology, 2001
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionGene, 1989